Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Torunn I. Yock, M.D., M.Ch.

Co-Author

This page shows the publications co-authored by Torunn Yock and Shannon MacDonald.
Connection Strength

10.039
  1. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9.
    View in: PubMed
    Score: 0.569
  2. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):121-9.
    View in: PubMed
    Score: 0.449
  3. Proton beam therapy following resection for childhood ependymoma. Childs Nerv Syst. 2010 Mar; 26(3):285-91.
    View in: PubMed
    Score: 0.437
  4. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):979-86.
    View in: PubMed
    Score: 0.386
  5. Bicentric Treatment Outcomes After Proton Therapy for Nonmyxopapillary High-Grade Spinal Cord Ependymoma in Children. Int J Radiat Oncol Biol Phys. 2021 Sep 29.
    View in: PubMed
    Score: 0.247
  6. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma. Cancer. 2021 Oct 15; 127(20):3840-3846.
    View in: PubMed
    Score: 0.244
  7. Clinical outcomes of pediatric patients with autism spectrum disorder and other neurodevelopmental disorders and intracranial germ cell tumors. Pediatr Blood Cancer. 2021 Aug; 68(8):e28935.
    View in: PubMed
    Score: 0.238
  8. Proton Radiation Therapy for Pediatric Craniopharyngioma. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1480-1487.
    View in: PubMed
    Score: 0.238
  9. Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1044-1052.
    View in: PubMed
    Score: 0.236
  10. Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy. Neuro Oncol. 2021 01 30; 23(1):156-166.
    View in: PubMed
    Score: 0.236
  11. Proton Therapy for Pediatric Ependymoma: Mature Results From a Bicentric Study. Int J Radiat Oncol Biol Phys. 2021 07 01; 110(3):815-820.
    View in: PubMed
    Score: 0.236
  12. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):726-735.
    View in: PubMed
    Score: 0.233
  13. Long-term health-related quality of life in pediatric brain tumor survivors receiving proton radiotherapy at <4 years of age. Neuro Oncol. 2020 09 29; 22(9):1379-1387.
    View in: PubMed
    Score: 0.231
  14. Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry. Radiother Oncol. 2019 05; 134:25-29.
    View in: PubMed
    Score: 0.206
  15. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.199
  16. Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up. Cancer. 2018 08; 124(16):3390-3400.
    View in: PubMed
    Score: 0.197
  17. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):391-398.
    View in: PubMed
    Score: 0.197
  18. Estimated IQ Systematically Underestimates Neurocognitive Sequelae in Irradiated Pediatric Brain Tumor Survivors. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):541-549.
    View in: PubMed
    Score: 0.194
  19. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors. Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):719-729.
    View in: PubMed
    Score: 0.189
  20. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients. Int J Radiat Oncol Biol Phys. 2017 05 01; 98(1):37-46.
    View in: PubMed
    Score: 0.179
  21. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 05; 17(5):e174-5.
    View in: PubMed
    Score: 0.170
  22. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-298.
    View in: PubMed
    Score: 0.167
  23. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 06; 18(6):881-7.
    View in: PubMed
    Score: 0.166
  24. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):287-296.
    View in: PubMed
    Score: 0.163
  25. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):133-138.
    View in: PubMed
    Score: 0.163
  26. Use of proton therapy for re-irradiation in pediatric intracranial ependymoma. Radiother Oncol. 2015 Aug; 116(2):301-8.
    View in: PubMed
    Score: 0.161
  27. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):400-7.
    View in: PubMed
    Score: 0.160
  28. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):358-67.
    View in: PubMed
    Score: 0.158
  29. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8.
    View in: PubMed
    Score: 0.157
  30. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015 May 15; 121(10):1694-702.
    View in: PubMed
    Score: 0.156
  31. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation. Radiat Oncol. 2014 Nov 18; 9:220.
    View in: PubMed
    Score: 0.154
  32. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20; 32(33):3762-70.
    View in: PubMed
    Score: 0.153
  33. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol. 2014 Oct; 113(1):77-83.
    View in: PubMed
    Score: 0.153
  34. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014 Oct; 113(1):89-94.
    View in: PubMed
    Score: 0.152
  35. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-1068.
    View in: PubMed
    Score: 0.150
  36. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):655-63.
    View in: PubMed
    Score: 0.146
  37. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014 Jan 01; 120(1):126-33.
    View in: PubMed
    Score: 0.142
  38. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer. 2013 Dec 15; 119(24):4299-307.
    View in: PubMed
    Score: 0.142
  39. Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr. 2013 Nov; 163(5):1448-53.
    View in: PubMed
    Score: 0.140
  40. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):120-6.
    View in: PubMed
    Score: 0.139
  41. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications. Neuro Oncol. 2013 Jul; 15(7):955-60.
    View in: PubMed
    Score: 0.138
  42. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):114-20.
    View in: PubMed
    Score: 0.137
  43. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012 Jun 10; 30(17):2079-86.
    View in: PubMed
    Score: 0.129
  44. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):1015-22.
    View in: PubMed
    Score: 0.125
  45. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8.
    View in: PubMed
    Score: 0.123
  46. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):635-42.
    View in: PubMed
    Score: 0.119
  47. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1367-73.
    View in: PubMed
    Score: 0.116
  48. A phase II trial of proton radiotherapy for medulloblastoma: Preliminary results. J Clin Oncol. 2010 Jun 20; 28(18_suppl):CRA9507.
    View in: PubMed
    Score: 0.113
  49. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer. 2008 Dec; 62(3):351-5.
    View in: PubMed
    Score: 0.098
  50. Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma. J Clin Oncol. 2019 12 10; 37(35):3335-3339.
    View in: PubMed
    Score: 0.054
  51. Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1026-1030.
    View in: PubMed
    Score: 0.052
  52. Larry Emanuel Kun, March 10, 1946-May 27, 2018. Int J Radiat Oncol Biol Phys. 2019 Jan 01; 103(1):8-14.
    View in: PubMed
    Score: 0.051
  53. Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. Radiother Oncol. 2018 07; 128(1):44-55.
    View in: PubMed
    Score: 0.049
  54. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):152-168.
    View in: PubMed
    Score: 0.049
  55. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors. Cancer. 2018 05 15; 124(10):2238-2245.
    View in: PubMed
    Score: 0.048
  56. Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy. J Neurooncol. 2018 Mar; 137(1):119-126.
    View in: PubMed
    Score: 0.047
  57. Analysis of patient outcomes following proton radiation therapy for retinoblastoma. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):44-52.
    View in: PubMed
    Score: 0.045
  58. Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol. 2015; 5:261.
    View in: PubMed
    Score: 0.041
  59. Proton radiation therapy for the treatment of retinoblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):863-9.
    View in: PubMed
    Score: 0.038
  60. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol. 2013 Dec; 115(3):411-9.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.